Nov 012017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immunology-based protein therapeutics to treat patients suffering from severe, rare immune-mediated diseases, as well as various cancers, announced that today Sanjay Shukla, M.D., M.S.=> Read more

aTyr Pharma announces CMO Dr Sanjay Shukla to its Board of Directors as next CEO

From:: aTyr Pharma announces CMO Dr Sanjay Shukla to its Board of Directors as next CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: